Skip to Main Content

Paper Details

Variations in novel cellular therapy products manufacturing.
Cytotherapy
1
2020
HPCs, dendritic cells, hematopoietic progenitor cells, induced-pluripotent stem, lymphocytes, mesenchymal stromal cells, natural killer (NK) cells, neural cells, pancreatic islet cells, processed cells
Author NameAffiliation
Magali J FontaineUniversity of Maryland School of Medicine
David F StroncekBiomedical Excellence for Safer Transfusion (BEST) Center for Cellular Engineering, Clinical Center, National Institutes of Health
David F StroncekBiomedical Excellence for Safer Transfusion (BEST) Center for Cellular Engineering, Clinical Center, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2